The cardioprotective role of beta-blockers in patients with diabetes mellitus.

The cardioprotective role of beta-blockers in patients with diabetes mellitus.

This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Landray, M, Toescu, V, Kendall, M
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2002

Eitemau Tebyg

Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
gan: A T Teplyakov, et al.
Cyhoeddwyd: (2009-03-01)

Cardioprotective role of oleanolic acid in patients with type 2 diabetes mellitus
gan: Chengrui Li, et al.
Cyhoeddwyd: (2024-06-01)

Hypoglycemia with Beta-Blocker in Patients with Type II Diabetes
gan: Rehmat Wali, et al.
Cyhoeddwyd: (2023-07-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
gan: M. A. Maksimova, et al.
Cyhoeddwyd: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
gan: M. A. Maksimova, et al.
Cyhoeddwyd: (2015-09-01)

The role of beta blockers in open angle glaucoma
gan: Marmion V
Cyhoeddwyd: (1982-01-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
gan: A. A. Aleksandrov, et al.
Cyhoeddwyd: (2016-01-01)

Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection
gan: Elena Nikolaevna Trunina, et al.
Cyhoeddwyd: (2011-06-01)

A systematic review and meta-analysis of the effects of diuretics and beta-blockers on glycaemic control in diabetes mellitus
gan: Hirst, J, et al.
Cyhoeddwyd: (2014)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
gan: A. A. Taylor, et al.
Cyhoeddwyd: (2011-08-01)

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
gan: Wai Bryan, et al.
Cyhoeddwyd: (2012-02-01)

Metabolomics of beta-blockers
gan: Tan, Ian Yong Ming.
Cyhoeddwyd: (2010)

The discovery of beta-blockers
gan: Subir Kumar Maulik
Cyhoeddwyd: (2018-01-01)

Beta-blockers in cardiac failure.
gan: Neubauer, G, et al.
Cyhoeddwyd: (1994)

The Place for Calcium Channel Blockers in the Treatment of Hypertension in Patients with Diabetes Mellitus
gan: Tarif Nauman, et al.
Cyhoeddwyd: (2000-01-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
gan: Ol'ga Konstantinovna Vikulova, et al.
Cyhoeddwyd: (2009-09-01)

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
gan: Robin Lengton, et al.
Cyhoeddwyd: (2022-08-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
gan: R. I. Striuk, et al.
Cyhoeddwyd: (2015-12-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
gan: R. I. Striuk, et al.
Cyhoeddwyd: (2015-12-01)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
gan: Roberto F.E. Pedretti
Cyhoeddwyd: (2018-06-01)

Outcomes of beta-blocker pharmacotherapy in patients with heart failure
gan: Maletin Sanja D., et al.
Cyhoeddwyd: (2024-01-01)

Role of liquid membrane hypothesis in the biological actions of beta-blockers
gan: Nagappa, A., et al.
Cyhoeddwyd: (2003)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
gan: I. T. Murkamilov, et al.
Cyhoeddwyd: (2017-07-01)

Considerations for choosing of beta-blockers
gan: Zoltán Nádházi
Cyhoeddwyd: (2024-10-01)

Beta-blockers and the criteria of SIRS
gan: W Kittisupamongkol
Cyhoeddwyd: (2009-01-01)

Beta adrenergic blockers poisoning
gan: Tadić Milorad, et al.
Cyhoeddwyd: (2016-01-01)

beta blockers in hypertension Reply
gan: Rothwell, P
Cyhoeddwyd: (2010)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
gan: I V Fomin, et al.
Cyhoeddwyd: (2017-12-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
gan: Fomin I.V., et al.
Cyhoeddwyd: (2017-09-01)

Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus
gan: M.D. Ivanova, et al.
Cyhoeddwyd: (2015-04-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
gan: A. G. Arutyunov, et al.
Cyhoeddwyd: (2022-01-01)

Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
gan: Yu. V. Lapina, et al.
Cyhoeddwyd: (2008-08-01)

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis
gan: S. N. Shilov, et al.
Cyhoeddwyd: (2021-05-01)

Beta-blockers in modern glaucoma therapy. Review
gan: O. A. Kiseleva, et al.
Cyhoeddwyd: (2014-07-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
gan: A. V. Simanenkova, et al.
Cyhoeddwyd: (2021-07-01)

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
gan: A. O. Konradi, et al.
Cyhoeddwyd: (2018-12-01)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
gan: Heirim Lee, et al.
Cyhoeddwyd: (2022-10-01)

Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
gan: Haddiya I, et al.
Cyhoeddwyd: (2023-10-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
gan: Kazufumi Nakamura, et al.
Cyhoeddwyd: (2011-08-01)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
gan: Tilman Sauerbruch, et al.
Cyhoeddwyd: (2023-01-01)